Related references
Note: Only part of the references are listed.Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status
Yenna Lee et al.
CLINICAL ENDOCRINOLOGY (2014)
An FGF21-Adiponectin-Ceramide Axis Controls Energy Expenditure and Insulin Action in Mice
William L. Holland et al.
CELL METABOLISM (2013)
Serum levels of the adipokine fibroblast growth factor-21 are increased in preeclampsia
Holger Stepan et al.
CYTOKINE (2013)
Serum Levels of the Adipokine Progranulin Depend on Renal Function
Judit Richter et al.
DIABETES CARE (2013)
Response to Comment on: Richter et al. Serum Levels of the Adipokine Progranulin Depend on Renal Function. Diabetes Care 2013;36:410-414
Judit Richter et al.
DIABETES CARE (2013)
Fibroblast Growth Factor-21 (FGF21) Regulates Low-density Lipoprotein Receptor (LDLR) Levels in Cells via the E3-ubiquitin Ligase Mylip/Idol and the Canopy2 (Cnpy2)/Mylip-interacting Saposin-like Protein (Msap)
Hai Thi Do et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Circadian Rhythm of Circulating Fibroblast Growth Factor 21 Is Related to Diurnal Changes in Fatty Acids in Humans
Haoyong Yu et al.
CLINICAL CHEMISTRY (2011)
High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes A 5.4-year population-based prospective study in Chinese subjects
Cheng Chen et al.
DIABETES CARE (2011)
Serum FGF21 levels are increased in newly diagnosed type 2 diabetes with nonalcoholic fatty liver disease and associated with hsCRP levels independently
Xuesong Li et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Circulating FGF21 Levels Are Progressively Increased from the Early to End Stages of Chronic Kidney Diseases and Are Associated with Renal Function in Chinese
Zhuofeng Lin et al.
PLOS ONE (2011)
Fibroblast Growth Factor 21 Action in the Brain Increases Energy Expenditure and Insulin Sensitivity in Obese Rats
David A. Sarruf et al.
DIABETES (2010)
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Ffolliott M. Fisher et al.
DIABETES (2010)
Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia
Sebastian Stein et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis
Seung Hyeok Han et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2010)
Serum Levels of FGF-21 Are Increased in Coronary Heart Disease Patients and Are Independently Associated with Adverse Lipid Profile
Zhuofeng Lin et al.
PLOS ONE (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Adiponectin and inducible ischemia in patients with stable coronary heart disease: data from the Heart and Soul study
Mary H. Zhang et al.
ATHEROSCLEROSIS (2009)
Serum Levels of the Adipokine FGF21 Depend on Renal Function
Sebastian Stein et al.
DIABETES CARE (2009)
Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance
Alberto O. Chavez et al.
DIABETES CARE (2009)
Adiponectin Levels and Risk of Type 2 Diabetes A Systematic Review and Meta-analysis
Shanshan Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
Xinmei Zhang et al.
DIABETES (2008)
Fibroblast Growth Factor 21 Corrects Obesity in Mice
Tamer Coskun et al.
ENDOCRINOLOGY (2008)
Adipose tissue dysfunction in obesity, diabetes, and vascular diseases
Gideon R. Hajer et al.
EUROPEAN HEART JOURNAL (2008)
The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21
Alexei Kharitonenkov et al.
ENDOCRINOLOGY (2007)
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study
S Yusuf et al.
LANCET (2005)
FGF-21 as a novel metabolic regulator
A Kharitonenkov et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Preoperative and postoperative levels of interleukin-6 in patients with acute appendicitis - Comparison between open and laparoscopic appendectomy
M Almagor et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2005)
National kidney foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
AS Levey et al.
ANNALS OF INTERNAL MEDICINE (2003)
Risks and complications in 160 living kidney donors who underwent nephroureterectomy
M Siebels et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Obesity and insulin resistance
BB Kahn et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
